2.
121例N2-Ⅲa期NSCLC患者单因素生存分析
Univariate analysis of N2-Ⅲa NSCLC patients for identifying prognostic factors
| Items | n | Median survival time (mo) | Range | 5-yr OS (%) | P |
| OS: overal survival; NA: not applicable. | |||||
| Gender | 0.402 | ||||
| Male | 82 | 42.6 | 31.4-53.8 | 37.7 | |
| Female | 39 | 63.1 | 57.1-69.1 | 55.4 | |
| Age (yr) | 0.836 | ||||
| < 65 | 88 | 53.4 | 34.8-72.0 | 43.2 | |
| ≥65 | 33 | 42.6 | 26.9-58.3 | 43.1 | |
| Smoking index | 0.363 | ||||
| < 400 | 77 | 59.8 | 42.3-77.2 | 52.8 | |
| ≥400 | 44 | 42.6 | 28.1-57.1 | 33.3 | |
| Perioperative chemotherapy | 0.258 | ||||
| Yes | 100 | 48.1 | 34.4-61.8 | 40.0 | |
| No | 21 | NA | NA | 67.3 | |
| Incision | 0.118 | ||||
| Minimally invasive | 77 | 59.8 | 37.1-82.5 | 49.1 | |
| Thoracotomy | 44 | 28.9 | 4.87-53.0 | 34.6 | |
| Histological type | 0.057 | ||||
| Adenocarcinoma | 88 | 59.8 | 45.8-73.8 | 47.4 | |
| Non-adenocarcinoma | 33 | 26.7 | 7.2-46.3 | 34.5 | |
| Intravascular cancer | 0.089 | ||||
| Yes | 38 | 31.9 | 12.5-51.2 | 23.1 | |
| No | 83 | 61.2 | 46.3-76.1 | 52.3 | |
| Tumor diameter (cm) | 0.269 | ||||
| ≤3 | 50 | 50.3 | 28.2-72.4 | 44.1 | |
| > 3 | 71 | 42.6 | 15.0-70.2 | 42.5 | |
| N2 level | 0.001 | ||||
| Single N2 | 79 | 63.1 | NA | 58.3 | |
| Multiple N2 | 42 | 31.9 | 14.5-49.2 | 25.5 | |
| N2 classification | 0.020 | ||||
| Ⅲa1/a2 | 42 | 63.8 | NA | 52.7 | |
| Ⅲa3/a4 | 79 | 37.5 | 24.0-50.9 | 38.4 | |